Investors

Half year Median Technologies liquidity contract statement contracted with TP ICAP

15 July 2022, Sophia-Antipolis, France

Press release – For immediate release – 5:45 pm CEST

Half year Median Technologies liquidity contract statement contracted with TP ICAP

Under the liquidity contract entrusted by Median Technologies (FR0011049824 – ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account as of June 30, 2022:

  • 20,968 shares
  • €214,295.64  in cash

Transactions during the first half 2022:

BUY 116,754  shares 1,432,388.92 EUR 384 transactions
SELL 115,879  shares 1,418,747.39  EUR 356 transactions

For information, as of December 31st, 2021, the following resources were listed in the liquidity contract:

  • 20,093 shares
  • €231,217.09 in cash

For information, as of May 4th, 2020, when the new liquidity contract was set up, the following resources were listed in the liquidity account:

  • 4,404 shares
  • €173,829.64 in cash

The daily transaction table is provided in the appendix to this press release. TP ICAP (Europe) is authorized and regulated by the Autorité de Controle Prudentiel (ACPR) and the Autorité des Marchés Financiers (AMF).

About Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com

Contacts

Median Technologies

Emmanuelle Leygues
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Actifin  (Investors)

Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr

Alizé RP  (Press)

Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com